Haotian Liu
Haotian Liu
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
1,2,†,
Kai Huang
Kai Huang
3
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
4
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
5
Brandon Regional Hospital GME, HCA Healthcare/USF Morsani College of Medicine, Brandon, FL, United States
3,4,5,†,
Tao Li
Tao Li
6
Department of Bone and Soft-Tissue Tumor, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
6,†,
Tielong Yang
Tielong Yang
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
1,2,
Zhichao Liao
Zhichao Liao
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
1,2,
Chao Zhang
Chao Zhang
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
1,2,
Lijie Xiang
Lijie Xiang
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
1,2,
Yong Chen
Yong Chen
3
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
4
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
3,4,*,
Jilong Yang
Jilong Yang
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
1,2,*
1
Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
3
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
4
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
5
Brandon Regional Hospital GME, HCA Healthcare/USF Morsani College of Medicine, Brandon, FL, United States
6
Department of Bone and Soft-Tissue Tumor, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Yong Chen, chenyong@fudan.edu.cn; Jilong Yang, yangjilong@tjmuch.com
†These authors have contributed equally to this work
This article was submitted to Surgical Oncology, a section of the journal Frontiers in Oncology
Received 2021 Mar 31; Accepted 2021 Mar 31; Collection date 2021.
Keywords: desmoid tumor, recurrence, prediction, the web-based nomogram, tumor number, validation
Copyright © 2021 Liu, Huang, Li, Yang, Liao, Zhang, Xiang, Chen and Yang
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
